Global Vascular Access Devices Market Report and Forecast 2024-2032

Global Vascular Access Devices Market Outlook

The global vascular access devices market size was valued at USD 4.4 billion in 2023, driven by the increasing cases of obesity and diabetes across the globe. The market size is anticipated to grow at a CAGR of 6.5% during the forecast period of 2024-2032 to achieve a value of USD 7.8 billion by 2032.

Vascular Access Devices: Introduction

Vascular access devices (VADs) are thin, flexible, tube-like equipment that helps in providing long-term access to blood vessels. VADs are also called PICCs, ports, cannulas, drips, or IVs. Vascular access devices may rescue people with cystic fibrosis who need intravenous (IV) antibiotic treatments regularly, such as during an exacerbation. There are two main categories of vascular access devices: peripherally inserted central catheters (PICC) lines and ports.

Global Vascular Access Devices Market Analysis

The vascular access devices market demand is primarily being driven by the rising development in the market, along with the increasing efforts by the key players. The Teleflex Incorporated, a leading global provider of medical technologies, announced that Premier has awarded them a national agreement for Hemodynamic Monitoring Products and Accessories, a national agreement for Central Venous Access, a Sole Source for AscenDrive Central Venous Access, and a Sole Source for SURPASS Central Venous Access. Teleflex’s accessibility and competitiveness are expected to be influenced positively by this. This endorsement of Teleflex's products through these agreements not only affirms the quality and reliability of their offerings but also makes Teleflex a preferred name in the market, which will directly contribute to the vascular access devices market share.

Both the companies have agreed on some special pricing and terms negotiated by Premier, which will provide added incentives for healthcare providers to choose Teleflex’s solutions, which is expected to potentially influence their purchasing decisions on a broader scale and contribute to Teleflex’s market expansion and the global vascular access devices market growth.

The market demand is also driven by the increased prevalence of chronic diseases such as heart diseases and non-communicable diseases such as depression, hypertension, and obesity among others. The increasing technological advancement of vascular access devices is a major factor driving the market growth.

Global Vascular Access Devices Market Segmentations

Market Breakup by Device Type

• Central Vascular Access Devices
  • Peripherally Inserted
  • Central Catheters
  • Percutaneous Non-tunneled Catheters
  • Other Central Vascular Access Devices
• Peripheral Vascular Access Devices
  • Peripheral Catheter
  • Midline Catheter
  • Other Peripheral Vascular Access Devices

• Accessories

Market Breakup by Mode of Insertion

• Intravenous

• Subcutaneous

Market Breakup by Application

• Administration of Drugs

• Administration of Fluid and Nutrition

• Diagnostics and Testing

• Other Applications

Market Breakup by End User

• Hospitals

• Speciality Clinics

• Home Healthcare

• Others

Market Breakup by Region

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East and Africa

Global Vascular Access Devices Market Overview

The market growth is driven by the increased prevalence of non-communicable diseases and chronic diseases. These diseases include cancer, tuberculosis, cardiovascular disease, depression, obesity, diabetes, and hypertension, among other conditions. These medical conditions require vascular access procedures for intravenous antibiotic treatment and extraction of blood samples, among others. Due to the increased number of vascular access procedures, the market is expected to draw attention of key players to invest in manufacturing and development of advanced equipment to assist.

North America has been leading the vascular access devices market demand and is expected to dominate the market during the forecast period as well. According to the data released by the American Cancer Society, more than 1.9 million new cancer cases are expected to occur in the United States in 2023, excluding basal cell and squamous cell skin cancers. Followed by this data, cancer is expected to account for nearly 609,820 deaths in the United States. The data clearly determines that the demand for vascular access devices is expected to increase in the forecast period as a huge population is expected to be diagnosed with cancer, which will result in increased treatment demand for the condition in healthcare facilities, propelling the market growth.

Global Vascular Access Devices Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Becton, Dickinson and Company

• Baxter International Inc.

• B. Braun Melsungen AG

• Fresenius Medical Care AG & Co.

• NIPRO Medical Corporation

• Medtronic

• AngioDynamics

• Teleflex Incorporated

• Vygon SA

• Terumo Medical Corporation

• Cardinal Health

• Abbott

• Boston Scientific Corporation

• BIOTRONIK, Inc.

• Shanghai Puyi Medical Instruments Co, Ltd

Please note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Highlights of the Report